Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma.
Naboulsi W, Megger DA, Bracht T, Kohl M, Turewicz M, Eisenacher M, Voss DM, Schlaak JF, Hoffmann AC, Weber F, Baba HA, Meyer HE, Sitek B.
Naboulsi W, et al. Among authors: turewicz m.
J Proteome Res. 2016 Jan 4;15(1):38-47. doi: 10.1021/acs.jproteome.5b00420. Epub 2015 Dec 18.
J Proteome Res. 2016.
PMID: 26626371